Personalized, Transformative, Holistic
Personalized, Transformative, Holistic
Dr. Michelle weiner is Double board-certified in Interventional Pain Medicine, Physical Medicine and Rehabilitation. She is the Director of Integrative Pain Management at Spine and Wellness Centers of America. Dr. Weiner completed her residency and fellowship training at the University of Miami. She is a Clinical Assistant Professor at Nova Southeastern University College of Osteopathic Medicine. Dr. Weiner is a member of Florida’s Medical Cannabis Advisory Committee. Dr. Weiner’s unique approach to personalized integrative pain management allows her to treat the root cause of one’s pain and suffering, both physical and emotional, providing comprehensive and durable relief. She uses a biopsychosocial model including lifestyle and plant medicine to empower her patients to cultivate health and optimize quality of life. Dr. Weiner was trained in ketamine assisted psychotherapy by the Ketamine Training Center and incorporates a multidisciplinary patient centered approach. Her cannabis research focuses on using cannabis as a substitute for opioids in chronic pain patients and cannabis’s effect on seniors with chronic pain. Her research at the University of Miami compared psychedelic vs psycholytic doses of ketamine to treat chronic pain and depression. She is the Vice president of Mr Psychedelic Law, a not-for-profit with the mission of responsible legal reform of psilocybin in Florida. Dr weiner is a clinical advisor for Iter investments, a psychedelic fund and is passionate about exploring new paradigms.
Interventional Pain Management
Physical Medicine and Rehabilitation
University of Miami
Florida Atlantic University (FAU)
Florida International University (FIU)
Nova Southeastern University
Florida Gulf Coast University
“forging new pathways to wellness using evidence based plant and lifestyle medicine”
“Your perspective is limited by how much you know; expand your knowledge and you will transform your mind” – Bruce Lipton
Dr. Michelle Weiner is a unique player in the wellness industry and is known as South Florida’s Medical Cannabis and Ketamine-assisted psychotherapy expert and educator. She is currently involved in multiple research collaborations.
Let's be Blunt with Montel
Dr. Michelle Weiner shares a personal story that catapulted her interest in medicinal marijuana.
Chronic pain and depression diagnoses are skyrocketing. There is an urgent need for more effective treatments. Ketamine was recently established to alleviate pain and depression, but many gaps remain in the scientific literature.
© 2023 Dr. Michelle Weiner, DO, MPH
Literature suggests that the use of virtual reality distraction for adjunctive pain control has been successful. In clinical settings and experimental studies, participants immersed in a virtual reality experienced reduced levels of pain, general distress/unpleasantness and reported a desire to use virtual reality again during painful medical procedures.
There has been research into the use of virtual reality distraction for adjunctive pain control with significant success. There has been growing evidence for the use of EEG for the measurement of pain. It has also been suggested that virtual reality could be used an alternative to marijuana and opioids for pain management. Further implications have been seen specifically among chronic pain sufferers. This is especially interesting since there is a reduced risk of addiction as is seen associated with marijuana and opioid use. This study aims to investigate the effect of virtual reality distraction on pain perception.
Additionally, we intend to create a body of open source content for potential use by other investigators utilizing similar tools.
The intervention has the potential to relieve chronic pain sufferers of their pain with a non-invasive mechanism and minimal risk. The participants may experience a temporary decrease in the perception of pain during the course of the experiment or a distraction from said pain.
Pending IRB approval at UM
The purpose of this study is to identify what is effective and safe for older adults with chronic pain to develop an understanding of what educational materials are required for facilitate access to appropriate products at medical marijuana treatment centers (MMTC).
Survey older adults (> 50 years) with chronic pain who have MM access cards and receive their product from state-approved dispensaries to document: demographic/health data; patterns of use; product specifics; pain effects on daily life; pain-related medical conditions; education prior to MM purchase; helpful and problematic effects of MM use.
The proportion of Florida’s population that is 60 and older is growing more rapidly than other components of the population. Musculoskeletal disorders with associated chronic pain are a common problem in later life. Symptom management in older adults, including chronic pain management can be challenging (Briscoe, 2018). Medications, especially opioids, can increase the risk of confusion, constipation, falls and injury (Briscoe,2018). Medical marijuana (MM) is often recommended by doctors in the treatment of these medical conditions, guided by state law that defines qualifying conditions.
Medical marijuana use among older adults is growing at a rate more rapid than younger age groups (Lum, et al, 2019). The 2016 National Survey on Drug Use and Health estimated a 2.9% prevalence of marijuana use among this older population. However, the survey did not ascertain if use was for medical or recreational purposes (Han et al., 2016). Older adults may have important differences in pathophysiology, pharmacological interaction of medications, comorbid conditions, and toxicological responses to cannabis.
There is little evidence to evaluate the differences associated with medical marijuana use among older adults, such as individual reasons for use and problems arising with use (Haug et al., 2017).
Chronic pain is a major public health problem. Approximately 178 million (41%) adults in the U.S. age 18 and older suffer from at least one painful health condition (Nahin, et al, 2019).
In Florida, there are 327,492 medical marijuana card holders and chronic non-malignant pain was the No. 1 diagnosis for which patients are registered (The Florida Department of Health, Office of Medical Marijuana Use, 2020). Yet, it is not a qualifying condition, creating challenges for physicians wishing to support patient use of MM for chronic pain.
Chronic pain accounted for nearly 34 percent of diagnoses at certified dispensaries (The Florida Department of Health, Office of Medical Marijuana Use, 2019).
